Program – 63th Days H.P. Klotz – 2021
 |
« Heart & Hormones« |
Final program (updated 2021/05/04)
THURSDAY June 17th 2021
INTRODUCTION (08:45-09:00) –
CARDIAC HORMONAL REGULATION: (9h-11h)
- The heart, an endocrine gland: natriuretic peptides Pr Marie-Christine VANTYGHEM, Paris, France
- Androgen receptors, antihormones and cardiac arrhythmia Dr Joe Elie SALEM, Ile de France, France
- Ladies’ heart Pr Claire MOUNIER-VEHIER, Lille, France
- Cardiac complications of Turner syndrome Pr Sophie CHRISTIN-MAITRE, Paris, France
COFFEE BREAK: (11-11h30)
HEART and METABOLISM (11h30-13h)
- FGF23 and cardiovascular risk Pr Dominique PRIE, Paris, France
- Hypoglycemia and heart rhythm disorders in type 1 diabetes Pr Bogdan NICOLESCU-CATARGI, Bordeaux, France
- Cardiac complications of lipodystrophic syndromes Pr Corinne VIGOUROUX, Paris, France
LUNCH (13:00 -14:00)
PARATHYROID GLANDS and HEART (14h-15h30)
- PTH, a marker of cardiovascular risk Pr. Damien GRUSON, Bruxelles, Belgium
- Cardiac consequences of parathyroid disorders Pr Jens BOLLERSLEV, Olso, Norway
COFFEE BREAK (15h30-16h)
THYROIDE and HEART (16h -18h30)
- Thyroid hormone and tissue regeneration Dr Frédéric FLAMANT, Lyon, Paris
- Is there any reason to treat subclinical hypo and hyperthyroidism Pr Bernadette BIONDI, Naples, Italy
- Amiodarone-induced hyperthyroidism Pr Lionel GROUSSIN, Paris, France
- Cardiac complications of thyroid hormones resistance syndromes Dr Frédéric ILLOUZ, Angers, France
- Therapeutic applications of thyroid hormone analogues Dr Edward VISSER, Rotterdam, Netherlands
FRIDAY June 18th 2021
ALDOSTERONE and HEART (9h-10h30)
- Cardiac gluco- and mineralocorticoid receptors: from development to pathology Pr. Karen CHAPMAN, Edinburgh, Scotland
- Cardiac consequences of primary hyperaldosteronism Pr Gian Paolo ROSSI, Padova, Italy
- Antagonists of aldosterone receptors Pr Michel AZIZI, Paris, France
COFFEE BREAK (10h30-11h)
SEROTONINE and HEART (11h-12h30)
- Monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia Pr Craig STILES, Fox Lane, United Kingdom
- Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors Pr Christos TOUMPANAKIS, London, Royaume-Uni
LUNCH (12h30-13h30)
PHEOCHROMOCYTOMA and HEART (13h30-15h)
- Receptors and cardiovascular effects of catecholamines Dr Emmanuelle VIDAL-PETIOT, Paris, France
- Adrenergic cardiac pathway Dr Grégoire VANDECASTEELE, Paris, France
- Mechanisms and diagnosis of stress myocarditis; the heart of pheochromocytomas Dr Laurence AMAR, Paris, France
HEART and GH (15h-16h)
- Heart and acromegaly Pr Peter KAMENICKY, Paris, France
- The heart of GH deficiency and cardiac effects of treatment Pr Philippe CHANSON, Paris, France
CONCLUSION (16:00-16:15)
© SFE Mai 2021